Pfizer plans to sell $ 33.5 billion worth of Covid vaccines this year

2021-07-28T11:29:03.436Z

Pfizer has revised its outlook for annual sales and profits upwards. Pfizer's ambitions are revised upwards. The American laboratory Pfizer plans to sell this year for 33.5 billion dollars of vaccines against Covid-19 developed in partnership with the German BioNTech, thanks to orders for 2.1 billion doses worldwide. To read also: Vaccination: deliveries of Pfizer down and AstraZeneca shunned by the French This is far more than the $ 26 billion the group said it